This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Transitions UltraShape® Business To Direct Sales In Canada

YOKNEAM, Israel, Aug. 1, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic products and technology, announced today the complete transition of its UltraShape® business in Canada from its previous distribution network to the Company's Canadian headquarters in Toronto, Canada which includes, but is not limited to, sales, service and customer support. This news comes shortly following the Company's acquisition of UltraShape Ltd. on February 8, 2012.

(Logo: )

"The swift progress to Syneron's Canadian headquarters in Toronto represents our continued commitment to this region, its existing UltraShape customers, and is a positive step towards driving increased adoption of UltraShape in Canada," said Louis P. Scafuri, Chief Executive Officer of Syneron. "We are very excited to bring all entities of the UltraShape business in Canada closer to our strong existing infrastructure – providing new and existing UltraShape customers with direct access to the world-class business and service support that have earned Syneron its leading position in the worldwide medical aesthetic market."

The UltraShape Contour |V3 system, the latest model by UltraShape, is cleared and commercially available in Canada as well as in Europe, Canada, Latin America and Asia. For more information about UltraShape visit

About UltraShape ® UltraShape's proprietary technology emits patented pulsed focused ultrasound energy that prompt an instant mechanical (non-thermal) destruction of fat cells – selectively and permanently destroying unwanted fat cells in problematic areas such as the abdomen, flanks and thighs without affecting critical surrounding structures. The UltraShape Contour |V3 system, the latest model by UltraShape, is approved and commercially available within Syneron's worldwide network in Canada, Europe, Latin America and Asia.

About Syneron Medical Ltd. Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

SOURCE Syneron Medical Ltd.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs